tradingkey.logo
tradingkey.logo
Suchen

Nasus Pharma Ltd

NSRX
Zur Watchlist hinzufügen
3.640USD
+0.070+1.96%
Handelsschluss 09-23 16:00ET
42.62MMarktkapitalisierung
VerlustKGV TTM

Über Nasus Pharma Ltd Unternehmen

Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.

Nasus Pharma Ltd Profil

BörsenkürzelNSRX
Name des UnternehmensNasus Pharma Ltd
IPO-datumAug 13, 2025
CEOTeleman (Dan)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeAug 13
AddresseYigal Alon 65
StadtTEL AVIV-YAFO
BörseNASDAQ OMX – NASDAQ Basic Amex
LandIsrael
Postleitzahl- -
Telefon97237326616
Websitehttps://www.nasuspharma.com
BörsenkürzelNSRX
IPO-datumAug 13, 2025
CEOTeleman (Dan)

Führungskräfte von Nasus Pharma Ltd

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.92M
+1.20%
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.92M
+1.20%
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.92M
+1.20%
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
--
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
--
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
--
Dr. Tair Lapidot, Ph.D.
Dr. Tair Lapidot, Ph.D.
Vice President of Research and Development and Clinical Development
Vice President of Research and Development and Clinical Development
--
--
Dr. Galia Temtsin Kryaz, Ph.D.
Dr. Galia Temtsin Kryaz, Ph.D.
Director of CMC and Product Development
Director of CMC and Product Development
--
--
Mr. Oren Elmaliach
Mr. Oren Elmaliach
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Ronnie Hershman
Mr. Ronnie Hershman
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.92M
+1.20%
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.92M
+1.20%
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.92M
+1.20%
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
--
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
--
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Nasus Pharma Ltd?

Die fünf größten Anteilseigner von Nasus Pharma Ltd sind: Mr. Udi Gilboa
tradingkey.logo
Risikohinweis: Unsere Website und mobile App bieten lediglich allgemeine Informationen zu bestimmten Anlageprodukten. Finsights stellt keine Finanzberatung oder Empfehlung für ein Anlageprodukt bereit, und die Bereitstellung solcher Informationen darf nicht als Finanzberatung durch Finsights ausgelegt werden.
Anlageprodukte unterliegen erheblichen Anlagerisiken, einschließlich des möglichen Verlusts des investierten Kapitals und sind möglicherweise nicht für jeden geeignet. Die vergangene Wertentwicklung von Anlageprodukten ist nicht unbedingt ein Hinweis auf deren zukünftige Wertentwicklung.
Finsights kann Drittanbietern oder Partnern erlauben, Werbung auf unserer Website oder in unserer mobilen App oder in Teilen davon zu platzieren oder bereitzustellen. Finsights kann für diese Anzeigenvergütung erhalten, basierend auf Ihrer Interaktion mit den Werbeanzeigen.
© Urheberrecht: FINSIGHTS MEDIA PTE. LTD. Alle Rechte vorbehalten.